Trochlear implants and methods of use

Information

  • Patent Grant
  • 8852286
  • Patent Number
    8,852,286
  • Date Filed
    Wednesday, August 25, 2010
    14 years ago
  • Date Issued
    Tuesday, October 7, 2014
    10 years ago
Abstract
Implant devices, and method of using the same, are provided. The implant devices have an articular end and a stem, the stem having an oval-shaped cross-section. The articular end has an upper surface, a side surface, and a lower surface. The upper surface and lower surface each intersect the side surface. The upper surface has a first surface curvature, a central surface curvature, and a second surface curvature. The stem extends from the lower surface in a direction away from the upper surface of the articular end.
Description
FIELD OF THE INVENTION

This disclosure relates to devices and methods for the repair of articular cartilage defects. Particular embodiments of this disclosure relate to implants that serve as a replacement for diseased or damaged cartilage in joints such as human knees, including the trochlear groove, hips and shoulders.


BACKGROUND OF THE INVENTION

Cartilage acts as a pad between bones to reduce friction and prevent the bones from grinding against one another. Cartilage covers the articular surface of many, if not all, joints in the body. The smoothness and thickness of the cartilage are factors that determine the load-bearing characteristics and mobility of the joints. Over time, due to injury or heredity, however, lesions such as fissures, cracks or crazes can form in the cartilage. In some cases, osteochondral, the lesion penetrates to the subchondral surface of the bone. In other cases, chondral, the lesion does not penetrate to the subchondral surface of the bone. Lesions generally do not repair themselves—and if any repair is made it is generally insufficient to heal—leading to significant pain and disability, either acutely or over time.


One approach for regenerating new cartilage is autologous chondrocyte transplantation. This technique is complex and relatively costly. Other techniques, aimed at repair instead of regeneration, include debridement, lavage, microfracturing, drilling, and abrasion arthroplasty. These procedures generally involve penetrating the region of vascularization in the subchondral bone with an instrument until bleeding occurs. Formation of a fibrin clot differentiates into fibrocartilage, which then covers the defect site.


An alternative approach has been to undergo a total replacement of the joint. Such total replacements, however, are costly, high risk, and involve a long recovery time.


SUMMARY OF THE INVENTION

Definitions


In various illustrative embodiments, the terms “vertical axis” or “vertical” mean a direction from the top of a three-dimensional object to the bottom of the three-dimensional object.


In various illustrative embodiments, the terms “horizontal axis” or “horizontal” mean a direction from right of the three-dimensional object to the left of the three-dimensional object.


In various illustrative embodiments, the terms “depth axis” or “depth” mean a direction from the front of the three-dimensional object to the back of the three-dimensional object.


In various illustrative embodiments, the term “medial side” is made with reference to the medial side of a patient's joint.


In various illustrative embodiments, the term “lateral side” is made with reference to the lateral side of a patient's joint.


In various illustrative embodiments, the term “torus” means the surface of a toroid.


In various illustrative embodiments, the term “tubular radius” refers to the radius of the tube of a torus, as opposed to the “major radius” or “radius of revolution”, which are terms that refer to the radius from the center of the torus to the center of the tube.


In various illustrative embodiments, geometric terms such as “elliptical,” “oval”, “circle”, “sphere”, “cylinder”, and the like are used as references and for clarity of understanding, as would be understood by one of ordinary skill in the art. Accordingly, these terms should not be limited to strict Euclidean standard.


Various illustrating embodiments of the present invention provide implant devices, preferably for use in human joints, including the trochlear groove. In accordance with one aspect of an illustrating embodiment of the present disclosure an implant is provided which may include an articular end and a stem, optionally the stem has an oval-shaped cross-section. The articular end may have an upper surface, a side surface, and a lower surface. The upper surface and lower surface each intersect the side surface. The upper surface may have a first surface curvature, a central surface curvature, and a second surface curvature. The stem may extend in a direction away from the lower surface of the articular end.


In accordance with another aspect of an illustrating embodiment of the present invention, a method of repairing articular cartilage using the implant device is provided. The method of this illustrative embodiment may include locating articular cartilage having a lesion. An implant device, as described above, may be selected preferably having dimensions compatible with the lesion. A hole may be formed through the cartilage and subchondral bone, into the cancellous bone. The implant device may be inserted into the hole so that the lower and side surfaces of the articular end of the implant device abut against the prepared subchondral and cancellous bone and the stem of the implant device abuts against the prepared cancellous bone.


In the detailed description which follows in conjunction with the drawings, like parts are given like reference numerals, and the vertical, horizontal and depth axes of a given embodiment are specified explicitly in at least one drawing of an illustrative embodiment.





BRIEF DESCRIPTION OF THE DRAWINGS

The drawing figures are not necessarily to scale and certain features may be shown exaggerated in scale or in somewhat schematic form in the interest of clarity and conciseness, wherein:



FIG. 1 is a side view of one embodiment of an implant;



FIG. 2 is a top-down view of the implant of FIG. 1;



FIG. 3 is an alternative side view of the implant of FIG. 1;



FIG. 4 is a perspective view of the implant of FIG. 1;



FIG. 5 is a bottom-up view of the implant of FIG. 1;



FIG. 6 side view of an alternative embodiment of an implant;



FIG. 7 is a top-down view of the implant of FIG. 6; and



FIG. 8 is an alternative side view of the implant of FIG. 6.





DISCLOSURE OF ALTERNATIVE EMBODIMENTS


FIGS. 1 and 6 are illustrative embodiments of an implant 100, 100′ in which the vertical, V, horizontal, H, and depth, D, axes of this embodiment are depicted. The implant 100, 100′ may have an articular end 105, 105′ and a stem 110, 110′. The articular end 105, 105′ may be bound by three surfaces: an upper surface 115, 115′ a side surface 120, 120′ and a lower surface 125, 125′. The upper surface 115, 115′ and the lower surface 125, 125′ may each intersect the side surface 120, 120′. In an embodiment, the upper surface 115, 115′ may have a surface normal (not shown) at the saddle point 145, 145′ (described below) that may be approximately perpendicular to the lower surface 125, 125′. In an embodiment, a tangent H-D plane (not shown) to the saddle point 145, 145′ (descried below) may be approximately parallel to the lower surface 125, 125′. All of the surfaces of the articular end 105, 105′ preferably blend 155a, 155a′ into one another. The blend 155a, 155a′ may have an edge radius ranging from between about 0.1 millimeters to about 2 millimeters, alternatively about 1 millimeter, alternatively about 0.75 millimeters, and alternatively about 0.5 millimeters.


The upper surface 115, 115′ may be generally saddle shaped. For ease of reference, the upper surface 115, 115′ may be thought of as segmented into three regions of surface curvature: a first surface curvature 130, 130′, a central surface curvature 135, 135′, and a second surface curvature 140, 140′. The central surface curvature 135, 135′ may be tangent to, on its medial side, the first surface curvature 130, 130′. The central surface curvature 135, 135′ may be tangent to, on its lateral side, the second surface curvature 140, 140′.


The first surface curvature 130, 130′ may be formed of, or along, a partial right circular cone having an aperture ranging from between about 20° to about 80°, alternatively from between about 30° to about 70°, alternatively from between about 40° to about 60°, alternatively about 40°, alternatively about 50°, alternatively about 60°. The central surface curvature 135, 135′ may be formed of, or along, a partial torus having a minor radius ranging from between about 8 millimeters to about 40 millimeters, alternatively from between about 8 millimeters to about 30 millimeters, alternatively about 10 millimeters, alternatively about 12 millimeters, alternatively about 15 millimeters, and having a major radius ranging from between about 25 millimeters to about 70 millimeters, alternatively from between about 28 millimeters to about 68 millimeters, alternatively about 45 millimeters, alternatively about 48 millimeters, alternatively about 50 millimeters. The second surface curvature 140, 140′ may be formed of, or along, a partial right circular cone having an aperture ranging from between about 20° to about 80°, alternatively from between about 30° to about 70°, alternatively from between about 30° to about 50°, alternatively about 30°, alternatively about 40°, alternatively about 50°. In an embodiment, the aperture of the first surface curvature 130, 130′ may be between about 5° to about 15°, alternatively about 10°, greater than the aperture of the second surface curvature 140, 140′.


In an embodiment, the major radius of the central surface curvature 135, 135′ may be in a plane that may be offset in any direction from a central axis 150, 150′ of the stem 110, 110′ by an amount ranging from between about 0 to about 5 millimeters, alternatively from between about 1 to about 4 millimeters, alternatively about 3 millimeters, alternatively about 1 millimeter. In an embodiment, the major radius of the central surface curvature 135, 135′ may be in a plane that may be offset, along the H axis towards either the medial or lateral side of the implant 100, 100′, from a central axis 150, 150′ of the stem 110, 110′ by an amount ranging from between about 0 to about 5 millimeters, alternatively from between about 1 to about 4 millimeters, alternatively about 3 millimeters, alternatively about 1 millimeter. FIGS. 1-5 illustrate an implant 100 having a one millimeter medial offset and FIGS. 6-8 illustrate an implant 100′ having a three millimeter medial offset. The central surface curvature 135, 135′ may include, at its central position along its surface, a saddle point 145, 145′. In an embodiment, the length, along the vertical axis, from the saddle point 145, 145′ on the surface of the central surface curvature 135, 135′, to the lower surface 125, 125′ may range from between about 1 millimeter to about 6 millimeters, alternatively from between about 1 millimeter to about 5 millimeters, alternatively about 3.5 millimeters, and alternatively about 4.5 millimeters.


With reference to FIGS. 2, 4, 5, and 7, the side surface 120, 120′ of the articular end 105, 105′ may be generally cylindrical, and may have a diameter ranging from between about 10 millimeters to about 40 millimeters, alternatively from about 10 millimeters to about 30 millimeters, alternatively from about 20 millimeters to about 30 millimeters, alternatively about 25 millimeters, alternatively about 20 millimeters.


With reference to FIGS. 1, 3-6, and 8, the lower surface 125, 125′ may be generally planar, and together with the side surface 120, 120′ may form a generally right circular cylinder. The lower surface 125, 125′ may further blend into the side surface 120, 120′. The further blend 155b, 155b′ may have an edge radius ranging from between about 0.1 millimeters to about 2 millimeters, alternatively about 1 millimeter, alternatively about 0.75 millimeters, and alternatively about 0.5 millimeters.


The stem 110, 110′ may extend from the lower surface 125, 125′ of the articular end 105, 105′ in a general direction, along the vertical, V, axis away from the central surface curvature 135, 135′, a length ranging from between about 2 millimeters to about 10 millimeters, alternatively from about 4 millimeters to about 7 millimeters, alternatively about 5.5 millimeters. In an embodiment, the articular end 105, 105′ and the stem 110, 110′ are formed as a non-modular, uni-body, i.e., one integral piece without intervening mechanical connection.


The stem 110, 110′ may be formed of a single cylinder, a single-truncated conical shape, a protrusion having an oval-shaped cross-section, or an elliptic cylindrical shape. In an embodiment, the stem 110, 110′ may have a width, w, along the horizontal, H, axis of the stem 110, 110′ that may range from between about 1 millimeter to about 10 millimeters, alternatively from between about 3 millimeters to about 7 millimeters, alternatively about 5 millimeters, alternatively about 6 millimeters. In an embodiment, the stem 110, 110′, may have a depth, d, along the depth, D, axis of the stem 110, 110′ that may range from between about 5 millimeters to about 40 millimeters, alternatively from between about 8 millimeter to about 20 millimeters, alternatively about 10 millimeters, alternatively about 11.5 millimeters, alternatively about 13 millimeters. The lower surface 125, 125′ of the articular end 105, 105′ may blend into the stem 110, 110′ with a corner fillet 170, 170′. The corner fillet 170, 170′ may have a radius of about 1.5 millimeters.


The stem 110, 110′ may include one, or more, grooves 165, 165′ about its perimeter. The shape of the groove(s) 165, 165′ may be defined by a partial oval-shaped torus having a tubular radius ranging from about 0.25 millimeters to about 2 millimeters, alternatively from about 0.5 millimeters to about 1.75 millimeters, alternatively about 1.75 millimeters, alternatively about 1 millimeter. The groove(s) 165, 165′ may blend into the stem 110, 110′ with a blend having an edge radius of from about 0.1 millimeters to about 1 millimeters, alternatively about 0.8 millimeters.


The implant 100, 100′ many be manufactured from a variety of suitable materials, having the requisite strength and biocompatibility characteristics to function as an implant, including but not limited to any of the following, individually or in combination, graphite, pyrocarbon, ceramic, aluminum oxide, silicone nitride, silicone carbide or zirconium oxide; metal and metal alloys, e.g., Co—Cr—W—Ni, Co—Cr—Mo, CoCr alloys, CoCr molybdenum alloys, Cr—Ni—Mn alloys; powder metal alloys, 316L or other stainless steels, Ti and Ti alloys including Ti 6A1-4V ELI; polymers, e.g., polyurethane, polyethylene, polypropylene, thermoplastic elastomers, polyaryletherketones such as polyetherehterketone (PEEK) or polyetherketoneketone (PEKK); biomaterials such as polycaprolactone; and diffusion hardened materials such as Ti-13-13, zirconium and niobium. Moreover, the implant 100, 100′ may be coated with a variety of suitable materials, including any of the following, individually or in combination, porous coating systems on bone-contacting surfaces, hydrophilic coatings on load-bearing surfaces, hydroxyapatite coatings on bone-contacting surfaces, and tri-calcium phosphate on bone-contacting surfaces. Other suitable coatings include growth factors and other biological agents such as bone morphogenetic proteins (BMP's), transforming growth factor beta, among others. In an embodiment, the outer coating of the implant 100, 100′ may be harder than the core of the implant 100, 100′. Additionally, components of the invention may be molded or cast, hand-fabricated or machined.


In an illustrative embodiment, the implant 100, 100′ is composed of graphite and pyrocarbon. Preferably, the implant 100, 100′ is graphite and includes a coating of pyrocarbon. The pyrocarbon coating may have an average thickness of from about 100 to about 1000 microns, alternatively from about 200 microns to about 500 microns, alternatively from about 250 to about 500 microns, alternatively about 350 microns. The pyrocarbon coating may have an elastic modulus from about 15 gigapascals (“GPa”) to about 22 GPa, alternatively about 20 GPa. The pyrocarbon coating may further have a strength of at least 200 megapascals (“MPa”), alternatively at least about 300 MPa, alternatively at least about 400 MPa. The pyrocarbon elastic modulus and strength are preferably tested using four-point bend, third-point-loading substrated specimens of dimensions 25 millimeters by 6 millimeters by 0.4 millimeters. Preferably the pyrocarbon is pyrolytic carbon as described in Pure Pyrolytic Carbon: Preparation and Properties of a New Material, On-X Carbon for Mechanical Heart Valve Prostheses, Ely et al, J. Heart Valve Dis., Vol. 7, No. 6, A00534 (November 1998), alternatively pyrocarbon is pyrolytic carbon as described in the before-mentioned J. Heart Valve Dis. publication, but includes additional silicon.


The above-described implants 100, 100′ may be used to repair damaged articular cartilage in humans, including ankles, knees, wrists, elbows, shoulders, and the like joints. In another illustrative embodiment or a preferred method, a patient having articular cartilage damage may be identified. The patient is preferably fully informed of the risks associated of surgery, and consents to the same. An incision may be made near the damaged articular cartilage. The lesion to be repaired may be identified, and a implant having dimensions compatible with, the lesion may be selected. The implant may be slightly smaller or slightly larger than the lesion. In these embodiments, the implant may be from about 0.1 percent to about 20 percent smaller or larger than the lesion. A hole is then formed, i.e., drilled, punched, or broached, through the cartilage and the subchondral bone into the cancellous bone. Preferably, the dimensions of the hole are slightly less than the horizontal and depth dimensions of the stem 110, 110′ and the articular end 105, 105′ of the implant 100, 100′. This may be achieved, for example, by using a box chisel and then a dill bit. Preferably the minimum length of the hole is equal to or slightly greater than the length of the stem 110, 110′ of the implant 100, 100′, along the central axis 150, 150′ of the stem 110, 100′ plus the length from the lower surface 125, 125′, to the saddle point 145, 145′. An amount of healthy and damaged cartilage may be removed near the lesion so that the lower surface 125, 125′ of the articular end 105, 105′ may rest against the patient's bone. The stem 110, 110′ of the implant 100, 100′ may be inserted into the hole, and the lower surface 125, 125′ of the implant's 100, 100′ articular end 105, 105′ may rest against the bone. The incision is then sutured by any of several known methods.


While specific alternatives to steps of the specific embodiments have been described herein, additional alternatives not specifically disclosed but known in the art are intended to fall within the scope of the invention. For example, while specific dimensions, and ranges of dimensions, have been provided further dimensions may reasonably fall within the scope of the invention. Thus, it is understood that other applications of the present invention will be apparent to those skilled in the art upon reading the descriptions of the described illustrative embodiments and after consideration of the appended claims and drawings.

Claims
  • 1. An implant comprising: an articular end having an upper surface, a side surface, and a lower surface;the upper surface and lower surface each intersect the side surface, the upper surface has a first surface curvature, a central surface curvature, and a second surface curvature, wherein the central surface curvature is formed along a partial torus and has a saddle point; anda stem, which extends from the lower surface in a direction away from the upper surface of the articular end and has a central axis, wherein the location of the saddle point is offset along a horizontal direction from the location of the central axis by a distance ranging from between about 1 to about 5 millimeters,the stem having at least one groove about a perimeter of the stem, the groove defined by a partial torus having a groove tubular radius ranging from about 0.25 millimeters to about 2 millimeters,the groove blending into the stem with a groove blend having an edge radius ranging from about 0.1 millimeters to about 1 millimeter,the groove extends continuously about the perimeter of the stem.
  • 2. The implant of claim 1, wherein the first surface curvature is formed along a partial right circular cone having an aperture ranging from between about 20° to about 80°, the central surface curvature is formed along the partial torus having a minor radius ranging from between about 8 millimeters to about 40 millimeters and a major radius ranging from about 25 millimeters to about 70 millimeters, and the second surface curvature is formed along a partial right circular cone having an aperture ranging from between about 20° to about 80°.
  • 3. The implant of claim 2, wherein the first surface curvature is formed along a partial right circular cone having an aperture ranging from between about 40° to about 60°, the central surface curvature is formed along the partial torus having a minor radius of about 12 millimeters and a major radius of about 48 millimeters, and the second surface curvature is formed along a partial right circular cone having an aperture ranging from between about 30° to about 50°, wherein the first surface aperture is between about 5° to about 15° greater than the second surface aperture.
  • 4. The implant of claim 1, wherein the location of the saddle point is offset, along the horizontal direction towards a medial side of the implant.
  • 5. The implant of claim 4, wherein a length, along a vertical axis parallel to the central axis of the stem, from the saddle point to a lower surface of the articular head ranges from between about 1 millimeter to about 6 millimeters.
  • 6. The implant of claim 5, wherein the side surface of the articular end is generally cylindrical, and has a diameter ranging from between about 10 millimeters to about 40 millimeters.
  • 7. The implant of claim 6, wherein the diameter is about 20 millimeters, the offset is either 1 millimeter or 3 millimeters, the first surface curvature is formed along a partial cone having an aperture selected from the group consisting of 40°, 50°, and 60°, and the second surface curvature is formed along a partial cone having an aperture angle selected from the group consisting of 30°, 40°, and 50°, and wherein the first surface aperture is 10° greater than the second surface aperture.
  • 8. The implant of claim 6, wherein the diameter is about 25 millimeters, the offset is either 1 millimeter or 3 millimeters, the first surface curvature is formed along a partial cone having an aperture selected from the group consisting of 40° and 50°, and the second surface curvature is formed along a partial cone having an aperture selected from the group consisting of 30° and 40°, and wherein the first surface aperture is 10° greater than the second surface aperture.
  • 9. The implant of claim 1, wherein the stem, having an oval shape, has a width distance ranging from between about 1 millimeter to about 6 millimeters and a depth distance ranging from between about 5 millimeters and about 40 millimeters.
  • 10. The implant of claim 9, wherein the oval-shaped stem has at least one groove about its perimeter, the at least one groove defined by the partial oval-shaped torus having a tubular radius ranging from about 0.25 millimeters to about 2 millimeters.
  • 11. The implant of claim 9, wherein the lower surface of the articular end blends into the oval-shaped stem with a corner fillet, the corner fillet having a radius of about 1.5 millimeters.
  • 12. The implant of claim 1, wherein the upper surface blends into the side surface; the side surface blends into the upper surface and the lower surface; and the lower surface blends into the side surface, and wherein each blend has an edge radius of from about 0.1 millimeters to about 2 millimeters, alternatively about 0.8 millimeters.
  • 13. The implant of claim 1, wherein the articular end and the oval-shaped stem are formed from graphite and pyrocarbon.
  • 14. The implant of claim 13, wherein the articular end and the oval-shaped stem comprise a graphite core and a pyrocarbon coating, the pyrocarbon coating having an elastic modulus from about 15 GPa to about 22 GPa, the pyrocarbon coating having an average thickness ranging from about 100 to about 1000 microns.
  • 15. The implant of claim 14, wherein the pyrocarbon coating has an elastic modulus of about 20 GPa and a strength of at least 400 MPa.
  • 16. The implant of claim 15, wherein the upper surface and contiguous edge blends are polished, and the lower surface and stem are coated with hydroxyapatite.
  • 17. The implant of claim 16, wherein the pyrocarbon coating is harder than the graphite core.
CROSS-REFERENCE TO RELATED APPLICATIONS

This patent application claims the benefit of U.S. Provisional Patent Application No. 61/236,811 filed Aug. 25, 2009.

US Referenced Citations (80)
Number Name Date Kind
4158894 Worrell Jun 1979 A
4231121 Lewis Nov 1980 A
4281419 Treace Aug 1981 A
4488843 Achille Dec 1984 A
4849692 Blood Jul 1989 A
4919667 Richmond Apr 1990 A
4945305 Blood Jul 1990 A
4964867 Boger Oct 1990 A
5019104 Whiteside et al. May 1991 A
5236462 Mikhail Aug 1993 A
5246460 Goodfellow et al. Sep 1993 A
5263987 Shah Nov 1993 A
5306311 Stone Apr 1994 A
5358525 Fox Oct 1994 A
5383937 Mikhail Jan 1995 A
5580353 Mendes et al. Dec 1996 A
5600330 Blood Feb 1997 A
5609640 Johnson Mar 1997 A
5645605 Klawitter Jul 1997 A
5742394 Hansen Apr 1998 A
5744953 Hansen Apr 1998 A
5749874 Schwartz May 1998 A
5767669 Hansen et al. Jun 1998 A
5767960 Orman et al. Jun 1998 A
5782835 Hart Jul 1998 A
5782927 Klawitter et al. Jul 1998 A
5831260 Hansen Nov 1998 A
5953683 Hansen et al. Sep 1999 A
6159247 Klawitter et al. Dec 2000 A
6172499 Ashe Jan 2001 B1
6217616 Ogilvie Apr 2001 B1
6246231 Ashe Jun 2001 B1
6417839 Odell Jul 2002 B1
6436146 Hassler et al. Aug 2002 B1
6473167 Odell Oct 2002 B1
6528991 Ashe Mar 2003 B2
6575986 Overaker Jun 2003 B2
6610067 Tallarida et al. Aug 2003 B2
6626945 Simon Sep 2003 B2
6626950 Brown Sep 2003 B2
6679917 Ek Jan 2004 B2
6699292 Ogilvie et al. Mar 2004 B2
6709460 Merchant Mar 2004 B2
D490900 Ogilvie et al. Jun 2004 S
6754596 Ashe Jun 2004 B2
6784660 Ashe Aug 2004 B2
6797006 Hodorek Sep 2004 B2
6814757 Kopylov et al. Nov 2004 B2
6815651 Odell Nov 2004 B2
6854972 Elian Feb 2005 B1
6856823 Ashe Feb 2005 B2
7027634 Odell Apr 2006 B2
7106431 Odell Sep 2006 B2
7161686 Duling et al. Jan 2007 B2
7204854 Guederian et al. Apr 2007 B2
7264634 Schmieding Sep 2007 B2
7314488 Reiley Jan 2008 B2
7713305 Ek May 2010 B2
8012217 Strzepa et al. Sep 2011 B2
20030135280 Kopylov et al. Jul 2003 A1
20030233149 Hodorek Dec 2003 A1
20040039447 Simon et al. Feb 2004 A1
20040230303 Gomes et al. Nov 2004 A1
20040230315 Ek Nov 2004 A1
20050033426 Ogilvie et al. Feb 2005 A1
20050084513 Tang Apr 2005 A1
20050137708 Clark Jun 2005 A1
20050137713 Bertram Jun 2005 A1
20060069446 Ragusa et al. Mar 2006 A1
20060190002 Tallarida et al. Aug 2006 A1
20060229726 Ek Oct 2006 A1
20060241778 Ogilvie Oct 2006 A1
20070032876 Clark Feb 2007 A1
20070078334 Scully et al. Apr 2007 A1
20070123993 Hassler et al. May 2007 A1
20070198095 Vander Meulen et al. Aug 2007 A1
20070225820 Thomas et al. Sep 2007 A1
20070250169 Lang Oct 2007 A1
20080188942 Brown et al. Aug 2008 A1
20090228104 Strzepa et al. Sep 2009 A1
Foreign Referenced Citations (27)
Number Date Country
2232068 Mar 1997 CA
69732500 Apr 2006 DE
602004003510 Aug 2007 DE
60126129 Nov 2007 DE
1112753 Feb 2001 EP
1437104 Jul 2004 EP
1955676 Aug 2008 EP
2141533 Mar 2000 ES
2004202233 Jul 2004 JP
WO-8802844 Apr 1988 WO
WO-9012276 Oct 1990 WO
WO-9203117 Mar 1992 WO
WO-9409280 Apr 1994 WO
WO-9602008 Jan 1996 WO
WO-9710780 Mar 1997 WO
WO-9819637 May 1998 WO
WO-0013617 Mar 2000 WO
WO-0133162 May 2001 WO
WO-0170138 Sep 2001 WO
WO-0243627 Jun 2002 WO
WO-2004093767 Nov 2004 WO
WO-2007041678 Apr 2007 WO
WO-2007059459 May 2007 WO
WO-2007103362 Sep 2007 WO
WO-2007109752 Sep 2007 WO
WO-2009111624 Sep 2009 WO
WO-2009111624 Dec 2009 WO
Non-Patent Literature Citations (18)
Entry
“Pyrocarbon in Orthopedics” downloaded from http://www.pyrocarbon.com/pyrocarbon-orthopedic-implant.php on Feb. 12, 2008, p. 1-4.
“Pyrolytic Carbon” downloaded from http://en.wikipedia.org/wiki/Pyrolytic—carbon on Feb. 12, 2008, p. 1-2.
PCT Internationa Search Report of the International Searching Authority for International Application No. PCT/US2009/049441, Aug. 26, 2009, p. 1-2.
PCT Written Opinion of the International Searching Authority for International Application No. PCT/US2009/049441, Aug. 26, 2009, p. 1-6.
PCT Internationa Search Report of the International Searching Authority for International Application No. PCT/US09/36159, May 13, 2009, p. 1-2.
PCT Written Opinion of the International Searching Authority for International Application No. PCT/US09/36159, May 13, 2009, p. 1-9.
“Pyrocarbon-Information for Surgeons” downloaded from http://www.pyrocarbon.com/index.php on Feb. 12, 2008.
Non-Final Office Action issued agains U.S. Appl. No. 12/074,770 on Oct. 28, 2009, p. 1-8.
Non-Final Office Action issued agains U.S. Appl. No. 12/074,770 on Dec. 28, 2009, p. 1-9.
Non-Final Office Action issued agains U.S. Appl. No. 12/074,770 on Apr. 27, 2010, p. 1-12.
Final Office Action issued against U.S. Appl. No. 12/074,770 on Aug. 31, 2010; p. 1-12.
PCT International Search Report Issued in Connection with International Application No. PCT/US2010/046654; Nov. 29, 2010; 1-5 pages.
PCT Written Opinion of the International Searching Authority Issued in Connection with International Application No. PCT/US2010/046654; Nov. 29, 2010; 1-8 pages.
Non-Final Office Action Issued Against U.S. Appl. No. 12/074,770; Nov. 24, 2010; 1-14 pages.
Non-Final Office Action Issued Against U.S. Appl. No. 12/319,869; Nov. 29, 2010; 1-16 pages.
Non-Final Office Action issued against U.S. Appl. No. 12/074,770 on Nov. 24, 2010; p. 1-14.
U.S. Patent and Trademark Office; Notice of Allowance and Fee(s) Due Issued in Connection with U.S. Appl. No. 12/319,869; Jun. 24, 2011; 13 pages; U.S.A.
U.S. Patent and Trademark Office; Non-Final Office Action Issued Against U.S. Appl. No. 12/396,872; Jul. 6, 2011; 18 pages; U.S.A.
Related Publications (1)
Number Date Country
20110054609 A1 Mar 2011 US
Provisional Applications (1)
Number Date Country
61236811 Aug 2009 US